EDITORIAL

Many scientists attempt to publish their work in a journal with the highest possible journal impact factor (IF). Despite widespread condemnation of the use of journal IFs to assess the significance of published work, these numbers continue to be widely misused in publication, hiring, funding, and promotion decisions (1, 2).
There are a number of problems with this approach. First of all, the journal IF is a journal-level metric, not an article-level metric, and its use to determine the impact of a single article is statistically flawed since citation distribution is skewed for all journals, with a very small number of articles driving the vast majority of citations (3, 4). Furthermore, impact does not equal importance (5) or advancement to the field, and the pursuit of a high IF, whether at the article or journal level, may misdirect research efforts away from more important priorities. The causes for the unhealthy obsession with IF are complex (2). High-IF journals limit the number of their publications to create an artificial scarcity and generate the perception that exclusivity is a marker of quality. The relentless pursuit of high-IF publications has been detrimental for science (2, 5). This behavior is an example of the economic phenomenon known as the “tragedy of the commons” (6), in which individuals engage in a behavior that benefits them individually at the expense of communal interests. Individual scientists receive disproportionate rewards for articles in high-IF journals, but science as a whole suffers from a distorted value system, delayed communication of results as authors shop for the journal with the highest IF that will publish their work, and perverse incentives for sloppy or dishonest work (2). Since many investigators consider IFs in deciding where to submit their manuscripts, many journals list their IFs on their websites, and until now American Society for Microbiology (ASM) journals have been no exception.
ASM journals focus on publishing high-quality science that has been rigorously peer reviewed by experts and evaluated by academic editors. The primary mission of ASM is to advance microbial science. At the recent Journals Board meeting that took place during ASM Microbe 2016 in Boston, MA, the editors in chief and the ASM leadership decided to no longer advertise the IFs of ASM journals (7).
Our goal is to avoid contributing further to the inappropriate focus on journal IFs. Although this action by itself may have little effect on a practice that is deeply entrenched in the biological sciences, we hope that removing IFs from ASM journal websites makes a statement of principle that will be emulated by other journals.

REFERENCES

1.
Cagan R. 2013. The San Francisco Declaration on Research Assessment. Dis Models Mech 6:869–870.
2.
Casadevall A, Fang FC. 2014. Causes for the persistence of impact factor mania. mBio 5:e00064-14.
3.
Kravitz DJ, Baker CI. 2011. Toward a new model of scientific publishing: discussion and a proposal. Front Comput Neurosci 5:55.
4.
Falagas ME, Kouranos VD, Michalopoulos A, Rodopoulou SP, Batsiou MA, Karageorgopoulos DE. 2010. Comparison of the distribution of citations received by articles published in high, moderate, and low impact factor journals in clinical medicine. Intern Med J 40:587–591.
5.
Casadevall A, Fang FC. 2015. Impacted science: impact is not importance. mBio 6:e01593-15.
6.
Hardin G. 1968. The tragedy of the commons. The population problem has no technical solution; it requires a fundamental extension in morality. Science 162:1243–1248.
7.
Bertuzzi S, Enquist LW, Campos J, Tiedje J, Donohue TJ, Sharp SE. 2016. Journal impact factors: changing the weather. Microbe 11:289.

Information & Contributors

Information

Published In

cover image mBio
mBio
Volume 7Number 47 September 2016
eLocator: 10.1128/mbio.01150-16

History

Published online: 11 July 2016

Notes

Editor's note: This editorial is published simultaneously by the following ASM journals: Antimicrobial Agents and Chemotherapy, Applied and Environmental Microbiology, Clinical Microbiology Reviews, Infection and Immunity, Journal of Clinical Microbiology, mBio, mSphere, and mSystems.

Contributors

Authors

Arturo Casadevall
Editor in Chief, mBio®
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Stefano Bertuzzi
Chief Executive Officer, ASM
American Society for Microbiology (ASM), Washington, DC, USA
Michael J. Buchmeier
Editor in Chief, Microbiology and Molecular Biology Reviews®
Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, California, USA
Roger J. Davis
Editor in Chief, Molecular and Cellular Biology®
Howard Hughes Medical Institute, Chevy Chase, Maryland, USA, and Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
Harold Drake
Editor in Chief, Applied and Environmental Microbiology®
Department of Ecological Microbiology, University of Bayreuth, Bayreuth, Germany
Ferric C. Fang
Editor in Chief, Infection and Immunity®
University of Washington School of Medicine, Seattle, Washington, USA
Jack Gilbert
Editor in Chief, mSystems
Department of Surgery, University of Chicago, Chicago, Illinois, USA
Barbara M. Goldman
Director, Journals, ASM
American Society for Microbiology (ASM), Washington, DC, USA
Michael J. Imperiale
Editor in Chief, mSphere
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA
Philip Matsumura
Editor, Genome Announcements
Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois, USA
Alexander J. McAdam
Editor in Chief, Journal of Clinical Microbiology®
Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Marcela F. Pasetti
Editor in Chief, Clinical and Vaccine Immunology®
Center for Vaccine Development and Department of Pediatrics, University of Maryland, Baltimore, Maryland, USA
Rozanne M. Sandri-Goldin
Editor in Chief, Journal of Virology®
Department of Microbiology and Molecular Genetics, University of California, Irvine, California, USA
Thomas Silhavy
Editor in Chief, Journal of Bacteriology®
Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA
Louis Rice
Editor in Chief, Antimicrobial Agents and Chemotherapy®
Departments of Medicine and Microbiology and Immunology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
Editor in Chief, Clinical Microbiology Reviews®
Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
Thomas Shenk
Chair, Publications Board, ASM
Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA

Notes

Address correspondence to Arturo Casadevall, [email protected].

Metrics & Citations

Metrics

Note: There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.

Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy